Epidarex Capital



Macomics secures £3.2m funding from Epidarex Capital

Edinburgh-based immune-oncology firm Macomics has secured £3.2 million seed funding from Epidarex Capital and the Scottish Investment Bank.

Published 15 July 2020

Epidarex Capital launches £102m venture fund in Edinburgh to support life science firms

International finance firm Epidarex Capital has launched a £102 million venture fund in Edinburgh to build successful life science companies.

Published 22 June 2020